GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shanghai INT Medical Instruments Co Ltd (HKSE:01501) » Definitions » Long-Term Capital Lease Obligation

Shanghai INT Medical Instruments Co (HKSE:01501) Long-Term Capital Lease Obligation : HK$17.1 Mil (As of Dec. 2023)


View and export this data going back to 2019. Start your Free Trial

What is Shanghai INT Medical Instruments Co Long-Term Capital Lease Obligation?

Shanghai INT Medical Instruments Co's Long-Term Capital Lease Obligation for the quarter that ended in Dec. 2023 was HK$17.1 Mil.

Shanghai INT Medical Instruments Co's quarterly Long-Term Capital Lease Obligation declined from Dec. 2022 (HK$17.8 Mil) to Jun. 2023 (HK$16.7 Mil) but then increased from Jun. 2023 (HK$16.7 Mil) to Dec. 2023 (HK$17.1 Mil).

Shanghai INT Medical Instruments Co's annual Long-Term Capital Lease Obligation increased from Dec. 2021 (HK$16.2 Mil) to Dec. 2022 (HK$17.8 Mil) but then declined from Dec. 2022 (HK$17.8 Mil) to Dec. 2023 (HK$17.1 Mil).


Shanghai INT Medical Instruments Co Long-Term Capital Lease Obligation Historical Data

The historical data trend for Shanghai INT Medical Instruments Co's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai INT Medical Instruments Co Long-Term Capital Lease Obligation Chart

Shanghai INT Medical Instruments Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Long-Term Capital Lease Obligation
Get a 7-Day Free Trial 1.80 1.68 16.18 17.81 17.12

Shanghai INT Medical Instruments Co Semi-Annual Data
Dec16 Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Long-Term Capital Lease Obligation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.18 15.71 17.81 16.72 17.12

Shanghai INT Medical Instruments Co  (HKSE:01501) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Shanghai INT Medical Instruments Co Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Shanghai INT Medical Instruments Co's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai INT Medical Instruments Co (HKSE:01501) Business Description

Traded in Other Exchanges
N/A
Address
No. 925 Jin Yuan Yi Road, Block 2, Jiading District, Shanghai, CHN, 201803
Shanghai INT Medical Instruments Co Ltd formerly Shanghai Kindly Medical Instruments Co Ltd is a manufacturer of cardiovascular interventional devices, which are mainly used in cardiovascular surgeries, and in particular, PCI procedures in China. It is engaged in the sales, manufacture, research, and development of cardiovascular interventional medical devices as well as related accessories and molds. It is also engaged in the research and development of other interventional and implantable medical devices, such as neurological interventional medical devices and endocardia implantable medical devices, among others. Geographically, it has operations in Mainland China, Europe, the United States, and Other countries.

Shanghai INT Medical Instruments Co (HKSE:01501) Headlines

No Headlines